Get the Stockscreener App
14.33
2.65%
-0.39
Hutchmed China Limited Adr stock is traded at $14.33, with a volume of 19,957.
It is down -2.65% in the last 24 hours and down -5.97% over the past month.
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
See More
Previous Close:
$14.72
Open:
$14.38
24h Volume:
19,957
Relative Volume:
0.59
Market Cap:
$2.46B
Revenue:
$603.63M
Net Income/Loss:
$468.71M
P/E Ratio:
5.343
EPS:
2.682
Net Cash Flow:
$-59.92M
1W Performance:
-6.28%
1M Performance:
-5.97%
6M Performance:
-4.21%
1Y Performance:
-13.83%
1-Day Range:
$14.32
$15.07
1-Week Range:
$14.31
$15.24
52-Week Range:
$11.51
$19.50
Hutchmed China Limited Adr Stock (HCM) Company Profile
Compare HCM vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCM
Hutchmed China Limited Adr
|
14.33 | 2.53B | 603.63M | 468.71M | -59.92M | 2.682 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.75 | 58.54B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
131.10 | 54.78B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
11.07 | 47.92B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.86 | 39.33B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
503.90 | 21.68B | 3.13B | 1.27B | 1.12B | 26.39 |
Hutchmed China Limited Adr Stock (HCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-22-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-13-25 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-24-23 | Upgrade | Deutsche Bank | Hold → Buy |
| May-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-22-21 | Downgrade | Goldman | Buy → Neutral |
| Aug-03-21 | Initiated | Jefferies | Buy |
| Oct-02-20 | Initiated | Deutsche Bank | Buy |
| Mar-13-20 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-20-20 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | CLSA | Buy |
| Oct-23-19 | Reiterated | BofA/Merrill | Buy |
| Jul-05-19 | Initiated | Macquarie | Outperform |
View All
Hutchmed China Limited Adr Stock (HCM) Latest News
JPMorgan Chase & Co. Has $729.86 Million Stock Holdings in iShares ESG Aware MSCI EAFE ETF $ESGD - Defense World
Glenview Trust Co Raises Stock Position in Vanguard Intermediate-Term Corporate Bond ETF $VCIT - Defense World
Shopify Inc. $SHOP Position Trimmed by Pallas Capital Advisors LLC - Defense World
HUTCHMED (NASDAQ:HCM) Shares Pass Above Fifty Day Moving AverageHere's Why - MarketBeat
UOB Kay Hian Favors ALI HEALTH, PA GOODDOCTOR; AI Innovation & National Policies Drive CN Internet Healthcare Sector - AASTOCKS.com
Cipher Mining (NASDAQ:CIFR) Shares Gap Up – Still a Buy? - Defense World
Brokerages Set HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) PT at $20.88 - Defense World
Travelzoo (NASDAQ:TZOO) Receives $19.67 Average PT from Analysts - Defense World
HUTCHMED to Announce 2025 Final Results - GlobeNewswire Inc.
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
BOCOMI Expects Pharma Sector to Continue Stable Improvement This Yr, Recommends Seeking Undervalued Pharma - AASTOCKS.com
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Short Interest Down 12.6% in January - MarketBeat
Paycom Software, Inc. (PAYC): A Bull Case Theory - Finviz
HUTCHMED (NASDAQ:HCM) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
HUTCHMED (NASDAQ:HCM) Shares Gap UpHere's What Happened - MarketBeat
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet - The Manila Times
RCSHutchmed China LtdPublication of Phase III Results in The Lancet - TradingView
D.A. Davidson & CO. Reduces Stock Holdings in MP Materials Corp. $MP - Defense World
Dynavax Technologies Corporation (NASDAQ:DVAX) Receives Average Rating of “Hold” from Brokerages - Defense World
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Recommendation of “Hold” by Analysts - Defense World
Bausch Health Cos Inc. (NYSE:BHC) Given Consensus Rating of “Hold” by Analysts - Defense World
Urban Edge Properties (NYSE:UE) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Hawaiian Electric Industries, Inc. (NYSE:HE) Given Consensus Rating of “Hold” by Analysts - Defense World
Compass Diversified Holdings (NYSE:CODI) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Automatic Data Processing (NASDAQ:ADP) VP Sells $234,000.00 in Stock - Defense World
Why HUTCHMED (China) Limited Depositary Receipt stock could see breakout soonJuly 2025 Intraday Action & Stepwise Trade Execution Plans - ulpravda.ru
Wall Street Analysts Predict a 55.93% Upside in HUTCHMED (HCM): Here's What You Should Know - Finviz
HUTCHMED (NASDAQ:HCM) Trading 8.1% HigherHere's What Happened - MarketBeat
HUTCHMED (China) Limited ADR (HCM) Stock Price Today | Live Chart & News - Traders Union
Antofagasta (LON:ANTO) Reaches New 52-Week High – Here’s What Happened - Defense World
Glencore (LON:GLEN) Hits New 52-Week High – Here’s Why - Defense World
HUTCHMED (LON:HCM) Share Price Passes Below 200-Day Moving Average – Here’s What Happened - Defense World
HUTCHMED (NASDAQ:HCM) Sees Strong Trading Volume – Should You Buy? - Defense World
MACD Signals Flash Warning for The Hindustan Housing Company Limited StockMarket Entry Points & Free Navigate Market With Precision - bollywoodhelpline.com
HUTCHMED (NASDAQ:HCM) Sees Large Volume IncreaseShould You Buy? - MarketBeat
[6-K] HUTCHMED (China) Ltd Current Report (Foreign Issuer) | HCM SEC FilingForm 6-K - Stock Titan
REGHutchmed China LtdBlocklisting Six Monthly Return - TradingView — Track All Markets
HUTCHMED (NASDAQ:HCM) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Brokerages Set HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Target Price at $20.88 - Defense World
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors - GlobeNewswire
HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China - Chartmill
Bearish block trade of HUTCHMED(00013) 278.5K shares at $22.0, $6.127M turnover - AASTOCKS.com
Schroder Investment Management Group Has $38.82 Million Stock Holdings in HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat
HUTCHMED Share Movement in the (LSE:HCM) Landscape and FTSE Aim 100 - Kalkine Media
Forge Global Holdings, Inc. (NYSE:FRGE) Receives $42.00 Average Price Target from Analysts - Defense World
Rep. Lisa C. McClain Sells Off Shares of Gartner, Inc. (NYSE:IT) - Defense World
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Catalyst Funds Management Pty Ltd Sells 29,903 Shares of HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat
Hutchmed China Limited Adr Stock (HCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.37%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):